ABX & Chemo

Antimicrobials & Chemotherapeutic Drugs

Objectives

  • Differentiate patient-related and institution-related surgical infection risk factors.
  • Describe the SCIP measures related to the prevention of surgical site infection.
  • Discuss the signs and symptoms of anaphylaxis with the appropriate treatment.
  • Describe antimicrobial key considerations for special populations such as pregnancy and the elderly.
  • Differentiate pharmacological and perioperative considerations for commonly administered antimicrobials.
  • Compare and contrast commonly utilized topical antiseptics.
  • Differentiate drug classifications, mechanism of action, and adverse effects of commonly administered chemotherapeutic agents.

Antimicrobials

Patient-Related Surgical Infection Risk Factors
  • Extremes in age – Young children and the elderly have higher infection risks.
  • Poor nutritional status – Address malnutrition to enhance recovery and decrease infection risk.
  • Obesity – Increased tissue perfusion disruptions can lead to infections.
  • Diabetes mellitus – Impaired immune response increases risk of infections.
  • Glucose control – Poor glycemic control is associated with increased surgical site infections (SSIs).
  • Tobacco use – Smoking can compromise wound healing and immune function.
  • Coexisting infections – Patients with ongoing infections are at greater risk.
  • Peripheral vascular disease – Impaired blood flow can hinder healing and increase infection risk.
  • Altered immune response – Patients with immunosuppression may be at higher risk for infection.
  • Corticosteroid therapy – Suppresses the immune response, increasing SSI risk.
  • Preoperative skin prep – Proper preparation can significantly reduce infection rates.
  • Length of preoperative stay – Longer stays may correlate with higher infection risk.
Institution-Related Surgical Infection Risk Factors
  • Surgical experience – An experienced surgical team can reduce infection risk.
  • Surgical approach (e.g., open vs laparoscopic) – More invasive methods may have higher infection rates.
  • Duration of procedure – Longer surgeries increase infection risk.
  • Hospital environment and sterilization – Proper sterilization techniques are essential for infection prevention.
  • Maintenance of perioperative normothermia – Hypothermia during surgery increases infection risks.
Prophylaxis for Surgery
  • Timing – Recommended administration should be within 1 hour prior to surgical incision.
  • Short-acting agents may require intraoperative redosing for efficiency.
  • Duration of administration – Antimicrobials should not be given for more than 24 hours post-surgery.
  • Antibiotic specificity – The choice of antibiotic should be tailored to the surgical procedure type.
    • Cephalosporins are commonly used, exemplified by cefazolin.
    • Anaphylaxis to cephalosporins is rare, and cross-reactivity with penicillin allergy is about 1%.
Recommended Doses and Redosing Intervals for Commonly Used Antimicrobials for Surgical Prophylaxis
  • Cefazolin:
    • Recommended Dose: 2 g (3 g for patients weighing ≥120kg)
    • Pediatrics: 30 mg/kg
    • Elimination Half-life: 1.2-2.2 hours
    • Recommended Redosing Interval: 4 hours
  • Cefoxitin:
    • Recommended Dose: 2 g
    • Pediatrics: 40 mg/kg
    • Elimination Half-life: 0.7-1.1 hours
    • Recommended Redosing Interval: 2 hours
  • Clindamycin:
    • Recommended Dose: 900 mg
    • Pediatrics: 10 mg/kg
    • Elimination Half-life: 2-4 hours
    • Recommended Redosing Interval: 9 hours
  • Gentamicin:
    • Recommended Dose: 5 mg/kg based on dosing weight (single dose)
  • Piperacillin-tazobactam:
    • Recommended Dose: 3.375 g
    • Pediatrics: 2.5 mg/kg based on dosing weight
    • Elimination Half-life: 0.7-1.2 hours
    • Recommended Redosing Interval: 2 hours
  • Vancomycin:
    • Recommended Dose: 15 mg/kg
    • Infants 2-9 months: 80 mg/kg of the piperacillin component
    • Children >9 months and ≤40 kg: 100 mg/kg of the piperacillin component
    • Elimination Half-life: 4-8 hours
    • Recommended Redosing Interval: N/A
Antimicrobial Associated Drug Toxicity
  • Allergic reactions: can occur with all antimicrobials, but are more frequent with B-lactam derivatives.
  • Nephrotoxicity: often linked to aminoglycosides and polymyxins.
  • Ototoxicity: particularly noted with aminoglycosides and vancomycin (auditory neurotoxicity).
  • Seizures: may be caused by penicillins and metronidazole in certain patients.
  • Neuromuscular blockade: associated to aminoglycosides and metronidazole.
  • Teratogenicity: Concern for certain groups of antimicrobials, especially regarding pregnancy.
  • Tendinitis: attributed to fluoroquinolones.
Anaphylaxis
  • Timing – Usually occurs 30-60 minutes post-dosing.
  • Signs & Symptoms:
    • Urticaria (hives)
    • Bronchospasm (tightness of the chest or difficulty in breathing)
    • Hemodynamic instability (drop in blood pressure)
  • Treatment:
    • Administer epinephrine.
    • Administer histamine blockers (H1 & H2 blockers).
    • Consider steroids for more severe reactions.
Nosocomial Infections
  • Common types include:
    • Urinary tract infections
    • Respiratory tract infections
    • Bloodstream infections
  • Associated with devices:
    • Vascular access catheters
    • Ventilators
    • Urinary catheters
  • Common organisms involved include:
    • S. aureus
    • S. epidermidis
  • Initial therapy frequently involves vancomycin.
Special Considerations: Parturients (Pregnant Women)
  • Transfer through placenta: Most antimicrobials can pass from mother to fetus.
  • Risks include:
    • Pregnancy-related metabolic changes affecting drug efficacy and toxicity.
    • Concerns with teratogenicity particularly during early pregnancy (first trimester).
    • Delayed gastric emptying can diminish oral absorption.
  • Physiological changes that impact drugs include:
    • Increased maternal blood volume, GFR, and hepatic metabolism may reduce plasma antimicrobial concentrations.
Antimicrobials in Pregnancy
  • Penicillins:
    • Maternal Toxicity: Allergic reactions
    • Fetal Toxicity: None known
    • Excreted in colostrum: Trace
  • Cephalosporins:
    • Maternal Toxicity: Allergic reactions
    • Fetal Toxicity: None known
    • Excreted in colostrum: Trace
  • Aminoglycosides:
    • Maternal Toxicity: Ototoxicity
    • Fetal Toxicity: Ototoxicity
    • Excreted in colostrum: Yes
  • Clindamycin:
    • Maternal Toxicity: Allergic reactions
    • Fetal Toxicity: None known
    • Excreted in colostrum: Trace
  • Sulfonamides:
    • Maternal Toxicity: Allergic reactions
    • Fetal Toxicity: Kernicterus (at term)
    • Excreted in colostrum: Yes
Key Considerations for Elderly Patients
  • Altered Pharmacokinetics:
    • Altered PO Absorption: Decreased gastric acidity and gastrointestinal motility.
    • Altered Distribution: Increased total body fat and decreased plasma albumin can affect drug distribution.
    • Altered Metabolism: Reduced hepatic blood flow can hinder drug metabolism.
    • Altered Excretion: Lower GFR can impact renal clearance of medications.
Penicillins
  • Basic structure: Dicyclic nucleus consisting of thiazolidine ring + β-lactam ring.
  • Mechanism of Action (MOA):
    • Interferes with peptidoglycan synthesis, decreasing the availability of an inhibitor of murein hydrolase.
  • Resistance Mechanism: Bacterial production of β-lactamase, which hydrolyzes the β-lactam ring, rendering penicillin ineffective.
  • Clinical Indications: Effective for pneumococcal, streptococcal, and meningococcal infections.
Adverse Effects of Penicillins
  • Neurotoxicity: High-dose penicillin G IV in end-stage renal disease (ESRD) can lead to hyperkalemia.
  • Seizures and Arachnoiditis: Associated with intrathecal administration.
  • Excretion:
    • Plasma concentration decreases by 50% within 1 hour post-administration.
    • 10% is cleared by GFR; 90% through renal tubular secretion.
  • Duration of Action Considerations: Anuria can increase the elimination half-time of penicillin G by 10x.
  • Probenecid can extend the half-life by blocking renal tubular secretion.
Cephalosporins
  • MOA: Bactericidal by inhibiting cell wall synthesis.
  • Resistance Mechanism: Similar to penicillins, bacterial production of β-lactamase hydrolyzes the β-lactam ring.
  • Allergic Reactions: Occur in 1-10% of patients, mostly with cutaneous manifestations. Anaphylaxis occurs in an estimated ~0.02%.
  • Cross-reactivity with Penicillins: Rare, though cephalosporins and penicillins share a β-lactam ring.
Aminoglycosides (e.g., Gentamicin)
  • Indications: Bactericidal primarily against gram-negative bacteria.
  • Elimination: Mostly occurs through glomerular filtration; increased elimination half-life seen in renal dysfunction.
  • Side Effects:
    • Ototoxicity: Can lead to vestibular and/or auditory dysfunction.
    • Vestibular symptoms: nystagmus, vertigo, nausea, Meniere’s syndrome.
    • Auditory symptoms: tinnitus, pressure in ears, potential for deafness.
    • Nephrotoxicity: Resulting from accumulation in renal cortex leading to acute tubular necrosis.
    • Signs: inability to concentrate urine, proteinuria.
    • Skeletal Muscle Weakness: Connected to inhibition of calcium-mediated release of prejunctional Ach.
    • Risk Factors: Myasthenia gravis and prolonged drug exposure.
    • Treatment: Use of intravenous calcium to mitigate symptoms.
Lincosamides (e.g., Clindamycin)
  • MOA: Bactericidal against most gram-positive bacteria.
  • Side Effects:
    • Gastrointestinal intolerance and risk of pseudomembranous colitis.
    • Large doses can cause profound and long-lasting neuromuscular blockade due to decreased Ach release, not easily countered by calcium or anticholinesterase agents.
Vancomycin
  • MOA: Bactericidal glycopeptide, impairs gram-positive cell wall synthesis.
  • Indications: Treatment of severe staphylococcal infections (e.g., MRSA), enterococcal endocarditis, and in patients allergic to penicillins or cephalosporins.
  • Dosage: 10-15 mg/kg infused over 60 minutes; can be initiated 2 hours prior to surgery for prophylactic purposes.
  • Elimination: Primarily renal, prolonged in cases of renal failure.
  • Target Plasma Levels: Aim for 20-30 mcg/mL for efficacy.
Side Effects of Vancomycin
  • Anaphylaxis: Monitor for severe allergic responses.
  • Rapid Infusion Side Effects (

Topical Antiseptics

Alcohols
  • 70% ethyl alcohol: Effective in killing 90% of bacteria within 2 minutes.
    • Primarily reduces bacterial contamination; not effective against fungi or viruses.
    • Precautions: Highly flammable until evaporated; avoid pooling (e.g., at umbilicus) and do not drape until dry.
Chlorhexidine
  • Mechanism: Disrupts cell membranes of both gram-positive and gram-negative bacteria.
  • Usage: Provides continued antibacterial protection on the skin; commonly used for surgical scrubs and patient skin prep.
  • Caution: Not suitable for use in the eye or middle ear due to the alcohol base; potential for neurotoxicity.
Povidone-iodine (Betadine)
  • Action: Works effectively on bacteria, viruses, and spores.
  • Common Uses: Employed for surgical scrubs and skin preparation preoperatively.
  • Toxicity: Less toxic to the cornea compared to other antiseptics; rare iodine allergy can occur.

Chemotherapeutic Drugs

Cancer Overview
  • Impact: Second leading cause of death in the U.S., following heart disease.
  • Statistics: Approximately 38% of individuals will receive a cancer diagnosis; about 42% of cases may be preventable.
  • Pathophysiology: Uncontrolled cell division can decimate bodily functions; metastasis is the most clinically relevant factor.
Cancer Diagnosis & Treatment Options
  • Traditional Treatments:
    • Surgery
    • Radiation therapy
    • Chemotherapy
  • Cancer Genotyping: Identifies genetic abnormalities related to cancer; it is crucial for diagnosis, prognosis, and sometimes treatment strategies.
Common Chemotherapeutic Side Effects
  • Myelosuppression leading to:
    • Leukopenia
    • Thrombocytopenia
    • Anemia
  • Nausea/Vomiting/Diarrhea: Frequent side effects accompanied by electrolyte disturbances and decreased fluid volume.
  • Mucosal ulceration: Can severely affect quality of life.
  • Dermatitis and Alopecia: Skin and hair loss as common side effects in various therapies.
Classification of Chemotherapy Drugs
Drug Classes & Their Mechanisms
  • Alkylating agents:
    • Mechanism: Form covalent bonds with key molecules, damaging proteins, DNA, and RNA.
    • Examples: Cisplatin, carboplatin, chlorambucil, cyclophosphamide, ifosfamide.
  • Antimetabolites:
    • Mechanism: Structural analogs of naturally occurring metabolites involved in nucleic acid synthesis; either substitute for or compete with nucleotides.
    • Examples: 5-Fluorouracil, methotrexate, pemetrexed, mercaptopurine, gemcitabine.
  • Antitumor antibiotics:
    • Mechanism: Intercalate DNA and create free radicals causing strand breaks, critical in disrupting replication.
    • Examples: Bleomycin, anthracyclines (doxorubicin, epirubicin).
  • Topoisomerase inhibitors:
    • Mechanism: Control the 3-D structure of DNA and are responsible for unwinding DNA during replication.
    • Examples: Topoisomerase I - irinotecan, topotecan; Topoisomerase II - etoposide.
  • Tubulin-binding drugs:
    • Mechanism: Affect the mitotic spindle and cell shape/function by preventing microtubule formation/disassembly.
    • Examples: Vinca alkaloids (vincristine, vinorelbine), taxoids (docetaxel, paclitaxel).
  • Signal transduction modifiers:
    • Mechanism: Disrupt growth factor receptor interactions leading to unchecked cell division.
    • Examples: Hormonal treatments like antiestrogens (tamoxifen) and antiandrogens (flutamide).
Chemotherapeutic Uses & Side Effects
Common Chemotherapeutic Agents
  • Alkylating agents (Cyclophosphamide, Cisplatin):

    • Therapeutic Uses: Treats a variety of leukemias, lymphomas, myeloma, solid tumors.
    • Common Side Effects: Myelosuppression, mucositis, alopecia, seizures, renal failure.
  • Antimetabolites (Methotrexate, Fluorouracil):

    • Therapeutic Uses: Used for cancers such as breast, lung, and lymphomas.
    • Common Side Effects: Myelosuppression, mucositis, potential pneumonitis.
  • Antitumor antibiotics (Bleomycin, Doxorubicin):

    • Therapeutic Uses: Hodgkin’s disease, testicular cancer, etc.
    • Common Side Effects: Pulmonary fibrosis (bleomycin), cardiomyopathy (doxorubicin), allergic reactions.
  • Topoisomerase inhibitors (e.g., Irinotecan, Etoposide):

    • Therapeutic Uses: Effective against various solid tumors and leukemias.
    • Common Side Effects: Myelosuppression, risk of fribrosis, and allergic reactions.
  • Tubulin-binding drugs (Vincristine, Vinblastine):

    • Therapeutic Uses: Effective in lymphomas and small cell lung cancer.
    • Common Side Effects: Peripheral neuropathy, myelosuppression.

References

  • Pan, S. J., & Flood, P. (2022). Antimicrobials, antiseptics, disinfectants, and management of perioperative infection. In Flood, P. & Rathmell, J. P. (Eds.), Stoelting’s Pharmacology & Physiology in Anesthetic Practice, 6th ed. Philadelphia, PA: Wolters Kluwer Health.
  • Kristijansdottir, K., Bodenstine, T. M., & Noronha, S. (2021). Neoplasia. In N. C. Tkacs, L. L. Herrmann, & R. L. Johnson (Eds.), Advanced physiology and pathophysiology, pp. 215-240. Springer.
  • Patel, A. K., Urman, R. D., & Rathmell, J. P. (2022). Chemotherapeutic drugs. In Flood, P. & Rathmell, J. P. (Eds.), Stoelting’s Pharmacology & Physiology in Anesthetic Practice, 6th ed. Philadelphia, PA: Wolters Kluwer Health.